AC Immune (ACIU) Net Cash Flow (2016 - 2025)
AC Immune has reported Net Cash Flow over the past 10 years, most recently at -$1.2 million for Q4 2025.
- Quarterly Net Cash Flow fell 156.67% to -$1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.4 million through Mar 2026, up 124.85% year-over-year, with the annual reading at -$10.6 million for FY2025, 77.18% up from the prior year.
- Net Cash Flow was -$1.2 million for Q4 2025 at AC Immune, down from $2.6 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $54.0 million in Q4 2023 and troughed at -$51.2 million in Q2 2021.
- The 5-year median for Net Cash Flow is -$11.4 million (2021), against an average of -$7.2 million.
- Year-over-year, Net Cash Flow crashed 1408.62% in 2021 and then surged 527.1% in 2023.
- A 5-year view of Net Cash Flow shows it stood at -$11.2 million in 2021, then fell by 12.8% to -$12.7 million in 2022, then soared by 527.1% to $54.0 million in 2023, then crashed by 95.96% to $2.2 million in 2024, then crashed by 156.67% to -$1.2 million in 2025.
- Per Business Quant, the three most recent readings for ACIU's Net Cash Flow are -$1.2 million (Q4 2025), $2.6 million (Q3 2025), and $9.0 million (Q2 2025).